BioPharmaSpec Appoints Christopher D. Ziegenfuss as Vice President of US Operations, BioPharmaSpec Inc.

Malvern, PA. USA, March 16, 2018 BioPharmaSpec, a leading contract research organization (CRO) providing a full range of characterization services for the biotechnology industry, today announced the appointment of Christopher D. Ziegenfuss as Vice President of BioPharmaSpec Inc.

Christopher is an expert mass spectroscopist and  protein chemist, with 20 years experience in characterizing a broad range of biopharmaceuticals, from small Insulin-like polypeptides to complex Glycoproteins. This senior appointment recognizes Chris’s considerable experience across the full range of BioPharmaSpec’s analytical activities and the positive impact this has had on BioPharmaSpec continuing to exceed client expectations.

 Following his recent appointment, Chris said, “BioPharmaSpec is a team of driven and motivated scientists, with outstanding technical expertise and true dedication to our Clients. I am delighted to be a part of this team and to apply my knowledge and experience to our objectives of expanding our client base and making continued investment in new services, based on our Clients’ requirements”